NCCN Marks a Decade of Hematologic Malignancy Treatment Advances with Congress in San Francisco
On October 16–17, 2015, the NCCN 10th Annual Congress: Hematologic Malignancies will be held at the San Francisco Marriott Marquis in San Francisco, California.
The NCCN Annual Congress, which has been held in New York City in previous years, will be co-chaired by Ranjana H. Advani, MD, Stanford Cancer Institute, and Andrew D. Zelenetz, MD, Memorial Sloan Kettering Cancer Center.
Treatment of hematologic malignancies is increasingly complex. Issues relating to pathology, transplantation, and various new therapies require oncologists and hematologists to stay abreast of breakthrough advances. In addition, targeted therapies and oral treatments bring the latest benefits to patients. This congress focuses on the new approaches that have been incorporated into patient management, including the use of drugs, biologics, and diagnostics.
New for 2015 will be interactive patient case studies and panel discussions in which panelists will review and discuss interesting and challenging cases with the audience.
To view the full congress agenda or to register, visit NCCN.org/HEM.
NCCN Patient Resource Updated in Collaboration with the Esophageal Cancer Awareness Association
NCCN has published an updated and newly redesigned NCCN Guidelines for Patients: Esophageal Cancer. This publication is made possible in part through support from several organizations and individuals, including the Esophageal Cancer Awareness Association, a nonprofit organization dedicated to helping patients, caregivers, survivors, family members, and anyone at risk of the disease.
The NCCN Guidelines for Patients: Esophageal Cancer has been updated from Version 2013 to Version 2015 to reflect the most recent updates in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Esophageal Cancer. The 2015 version addresses appropriate referral to cancer genetics professionals, and new recommendations for surveillance have been added. Furthermore, information regarding the treatment of early cancers has been revised, and systemic therapy regimens have been updated. A digital version of the NCCN Guidelines for Patients: Esophageal Cancer can be downloaded free-of-charge on NCCN.org/patients.
NCCN currently offers NCCN Guidelines for Patients for Breast Cancer: Stages 0–IV; Colon, Esophageal, Non–Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults; Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma.
NCCN is committed to developing a comprehensive patient library with support from the NCCN Foundation.
New Abbreviated Patient Resource Available—NCCN Quick Guide for Prostate Cancer
NCCN has published the first NCCN Quick Guide for Prostate Cancer. This resource summarizes key points of the NCCN Guidelines for Patients: Prostate Cancer, Version 2015. Key points include recommendations for initial and subsequent treatment and suggestions for the decision-making process.
The NCCN Guidelines for Patients and NCCN Quick Guide for Prostate Cancer provide the same current and accurate cancer information on health care options that clinicians access in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
A digital version of the NCCN Quick Guide for Prostate Cancer is available free-of-charge on NCCN.org/patients.
NCCN currently offers NCCN Guidelines for Patients for the following: Breast Cancer: Stages 0–IV; Colon, Esophageal, Non–Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults; Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma. NCCN Quick Guide sheets are currently available for Stage IV Breast and Prostate Cancers, as well as Lung Cancer Screening.
NCCN is committed to developing a comprehensive patient library with support from the NCCN Foundation.
New NCCN Quick Guide for Esophageal Cancer Now Available
NCCN has published the first NCCN Quick Guide for Esophageal Cancer. This resource summarizes key points of the NCCN Guidelines for Patients: Esophageal Cancer, Version 2015, which was published in June. Key points include recommendations for treatment planning and treatment options for squamous cell carcinomas and adenocarcinomas. The NCCN Guidelines for Patients: Esophageal Cancer, Version 2015, is available, in part, through generous sponsorship from the Esophageal Cancer Awareness Association.
The NCCN Guidelines for Patients and NCCN Quick Guide for Esophageal Cancer provide the same current and accurate cancer information on health care options that clinicians access in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines).
Available free of charge, the NCCN Quick Guide for Esophageal Cancer can be downloaded and printed from NCCN.org/patients.
NCCN currently offers NCCN Guidelines for Patients for the following: Breast Cancer: Stages 0–IV, Colon, Esophageal, Non–Small Cell Lung, Ovarian, Pancreatic, and Prostate Cancers; Acute Lymphoblastic Leukemia; Caring for Adolescents and Young Adults; Chronic Myelogenous Leukemia; Malignant Pleural Mesothelioma; Melanoma; Multiple Myeloma; Lung Cancer Screening; and Soft Tissue Sarcoma. NCCN Quick Guide sheets are currently available for Stage IV Breast and Prostate Cancers, as well as Lung Cancer Screening.
NCCN is committed to developing a comprehensive patient library with support from the NCCN Foundation.
